Vaginal Clear Cell Adenocarcinoma — Trials

Vaginal Clear Cell Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1
Recruiting: 1
Ph III recruiting: 0
Growth YoY: —
Industry share: 100%
Top sponsor: MacroGenics
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (0)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06730347	A Study of Lorigerlimab in Participants With Advanced Solid Tumors	recruiting	Phase 2	80	MacroGenicsINDUSTRY	3	Jun 2, 2026	clinicaltrials

Data updated 22 days agoSource updated Jun 2, 2026source: clinicaltrials